Summary
Neko Health, a company co-founded by Spotify's Daniel Ek, has raised $700 million to bring its AI-powered body scanning service to the United States. The funding will help open clinics in New York and other cities, offering a 60-minute health check that combines scans, blood tests, and doctor reviews. The company has already completed over 100,000 scans in the UK and Sweden, and now aims to expand its preventive health model to American customers.
Main Impact
The $700 million investment marks a major step for Neko Health as it enters the US market. The company plans to open its first American clinic in New York, with more locations to follow. This expansion brings a new type of preventive health screening to US consumers, offering a full-body check that uses AI and custom sensors to spot early signs of conditions like skin cancer, heart disease, and diabetes. The funding round was led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from high-profile investors including Meta CEO Mark Zuckerberg, Priscilla Chan, Maria Sharapova, will.i.am, and Thierry Henry.
Key Details
What Happened
Neko Health raised $700 million in a Series C funding round to expand its AI body scanning service to the United States. The company will open a clinic in New York first, with plans for additional US cities. The service combines full-body scans, blood tests, AI analysis, and a doctor consultation in a single 60-minute appointment. The scan is non-invasive and radiation-free, using proprietary sensors to check for skin issues, blood problems, heart risks, and metabolic conditions.
Important Numbers and Facts
The latest funding brings Neko's total disclosed investment since 2023 to over $1 billion. The company previously raised $65 million in 2023 and $260 million in January 2025. Neko currently operates eight clinics in the UK and Sweden, including four in London. A scan costs £299 in the UK (about $400) and 2,750 Swedish kronor (about $285). The company has completed 100,000 scans since launching in 2023, with over 350,000 people on waitlists. About 75% of customers book and pay for another scan at the end of their appointment.
Background and Context
Neko Health was founded in 2018 by Spotify co-founder Daniel Ek and CEO Hjalmar Nilsonne. The company stayed quiet until launching its service in 2023. Its model combines medical tests that are already available separately, like blood pressure checks and cholesterol tests, into one appointment with proprietary imaging and AI analysis. The company says this approach makes preventive care more convenient and thorough. However, public materials do not include a completed study showing that this combined method improves health outcomes or saves money compared to standard care. Two of Neko's devices received FDA clearance in May 2026 for specific uses, but the full scan service is not FDA-approved as a single product.
Public or Industry Reaction
The funding round attracted a mix of venture capital firms and celebrity investors. David Ofer of O.G. Venture Partners will join Neko's board, pending regulatory approval. The company's waitlist for the New York clinic is already open, though pricing for US scans has not been announced. Neko's US clinics will operate as preventive health and wellness providers, not full medical practices. Customers are advised to continue seeing their regular doctors for diagnosis and treatment. The company does not currently accept health insurance, so customers will pay directly for the initial assessment.
What This Means Going Forward
Neko's expansion into the US market could change how Americans think about preventive health. The company plans to use part of the new funding for research and development of better screening technology. It has already added body-composition measurements and wearable-device data reviews to its services. Newer versions of its Derma, Echo, and Spectrum devices will be deployed across clinics in the coming months. However, questions remain about clinical evidence. Public information does not include a completed peer-reviewed study validating the full screening service, and the company has not disclosed how often scans produce false positives or how many customers need follow-up procedures. The US price and whether employers or insurers will subsidize access are also unknown.
Final Take
Neko Health's $700 million raise shows strong investor confidence in AI-driven preventive care. The company's expansion to the US brings a new option for people who want a quick, comprehensive health check. But without published clinical studies or clear pricing, it remains to be seen how the service will fit into the American healthcare system. The company's success will depend on whether it can prove that its scans lead to better health outcomes and whether customers are willing to pay out of pocket for the service.
Frequently Asked Questions
What does a Neko Health scan include?
A Neko Health scan is a 60-minute appointment that includes a full-body scan, blood tests, an electrocardiogram, body-composition analysis, and over 2,000 high-resolution skin images. The results are reviewed by a clinician during the same visit. The scan checks for signs of skin cancer, heart disease, diabetes, and other conditions.
How much does a Neko Health scan cost?
In the UK, a scan costs £299 (about $400). In Sweden, it costs 2,750 Swedish kronor (about $285). The price for US scans has not been announced yet. Neko's US clinics do not accept health insurance, so customers will pay directly for the service.
Is the Neko Health scan FDA-approved?
Two of Neko's devices received FDA clearance in May 2026 for specific uses. The Derma-2 device was cleared as a telethermographic system, and the Spectrum-2 device was cleared as a tissue-saturation oximeter. However, the complete Neko Health Scan service is not FDA-approved as a single product. The company operates its US clinics as preventive health and wellness providers, not full medical practices.
